Oncore Pharma Signs a Multi-Year Agreement Valued at $61.8 Million

Cambridge MA, Oct. 10, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Oncore Pharma Inc., a life sciences company specializing in blood-based biomarker tests for early cancer detection, announced today that it has signed a...

GeneNews Signs Global Licensing and Services Agreement with Oncore Pharma

According to the Agreement, Oncore Pharma and its partners will commercialize ColonSentry® in all countries other than the United States, under an exclusive license. GeneNews and Oncore Pharma will work together in Canada